	Epigenetic inflammation signatures and lung cancer risk among never-smoking women: a nested case-control study. medRxiv Rahman ML, Gargapati A, Hurwitz LM, Hu W, Keil AP, Breeze CE, Chaturvedi A, Shi J, Cai Q, Yang G, Long J, Gao YT, Christiani DC, Rothman N, Zheng W, Shu XO, Wong JYY, Lan Q. PMID: 42094136 [PubMed]
	Orchestration of the tumor microenvironment by citrus flavonoids: from preclinical mechanisms to translational therapeutic. Front Immunol Ma S, Wang X, Li M, Wang W, Ren Y, Shen Y, Yang K, Zhang Z, Feng Z, Tang S. PMID: 42094009 [PubMed - indexed for MEDLINE]
	Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms. Front Immunol He L, Sun Y, Ma B, Lang G, Wen J, Blumenschein GR Jr, Ma H. PMID: 42093990 [PubMed - indexed for MEDLINE]
	Shuangshen granules enhance anti-PD1 therapy effectiveness in lung adenocarcinoma by modulating myeloid-derived suppressor cell-induced T cell exhaustion. Chin Med He ZN, Huang Q, Li Y, Hu JQ, Liu TT, Zhao YW, Ren XL, He SL, Li Y, Shi BL, Liu R, Guo QJ, Zhang X, Shi Z, He J, Qi RZ, Hua BJ. PMID: 42092980 [PubMed]
	The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects. Respir Res Kong Q, Zhang L, Gong S, Wu Y, Wang J. PMID: 42092925 [PubMed - as supplied by publisher]
	Relationship between the advanced lung cancer inflammation index (ALI) and all-cause and cause-specific mortality among patients with chronic obstructive pulmonary disease (COPD): a population-based study. BMC Pulm Med Luo Z, Chen P, Chen L, Ma H, Cao C. PMID: 42092873 [PubMed - as supplied by publisher]
	Association of Coronary Calcification or Vascular Inflammation and Cardiovascular Events and Prognosis in Non-small Cell Lung Cancer: A Retrospective Study. Respir Med Hayashi M, Fujimoto K, Endo J, Matsumoto-Miyazaki J, Kanamori H, Matsuo M, Okura H. PMID: 42092596 [PubMed - as supplied by publisher]
	Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study. Sci Rep Masuda T, Watanabe S, Suzuki R, Yanai K, Yamazaki R, Ando Y, Wakabayashi T, Tanaka S, Shono K, Yanagimura N, Sato M, Tanaka T, Nozaki K, Saida Y, Shima K, Kimura Y, Aoki N, Ohshima Y, Koya T, Sakai K, Nishio K, Yamazaki M, Ishikawa H, Kikuchi T. PMID: 42092113 [PubMed - as supplied by publisher]
	Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming. Signal Transduct Target Ther Zhou L, Liu Y, Xing Z, Wu Y, Yang X, Chen S, Kang K, Wang M, Zhou Z, Huang M, Gong Y, Zhou L, Zhou X, Li J, Yao Z, Zheng Q, Kong FS, Niedermann G, Luo R, Lu Y, Xue J. PMID: 42091852 [PubMed - indexed for MEDLINE]
	The global clinical trial landscape of lung cancer cellular therapy current status trends and scientific challenges. Discov Oncol Song C, Lu DS, Zhao CY, Xu ZY, Peng HJ, Li XL, Zeng HY, Li JH, Guo JJ, Yang N. PMID: 42091781 [PubMed - as supplied by publisher]
	Diagnostic Challenge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Case Requiring Prostate Rebiopsy After an Inconclusive Metastatic Lung Biopsy. Intern Med Nakagaki S, Ito T, Sugiura K, Suzuki H, Morishita T, Taki S, Miyazawa A, Hayashi N, Hibino Y. PMID: 42091458 [PubMed - as supplied by publisher]
	Molecular Pathology of Lung Cancer. Surg Pathol Clin Lingard A, Dacic S. PMID: 42091274 [PubMed - indexed for MEDLINE]
	Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung Cancer. JCO Precis Oncol Bansal D, Ponvilawan B, Grachev D, Kushnarev V, Tarasov A, Valiev I, Danilov K, Butusova A, Turova P, Bagaev A, Kotlov N, Al-Obaidi A, Ward C, Subramanian J. PMID: 42090630 [PubMed - indexed for MEDLINE]
	Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review. Target Oncol Goto K, Hayashi H, Maruti SS, Zettl H, Mittal L, Pathak S, Le X. PMID: 42090048 [PubMed - as supplied by publisher]
	Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy. Eur Radiol Kalsi HS, Linton-Reid K, Kim C, Chen M, Crowe V, Alemu E, Mahboobani S, Gibeon D, Procter A, Hajhosseiny M, Owens C, Bartlett EC, Porta N, Thavaraja T, Doran S, Devaraj A, Sharma B, Nair A, Aboagye EO, Lee RW. PMID: 42089967 [PubMed - as supplied by publisher]
	The application and challenges of immune checkpoint inhibitors in lung cancer therapy. Front Immunol Li B, Ren Y, Zhang X. PMID: 42088497 [PubMed - indexed for MEDLINE]
	Efficacy and safety of local consolidative therapy combined with systemic therapy in driver-negative oligometastatic non-small cell lung cancer: a systematic review and meta-analysis. Front Oncol Han H, Li L, Park T, Yang Y, Alai G, Zhong C, Lin Y. PMID: 42088207 [PubMed]
	GCC2 in Small Extracellular Vesicles as a Diagnostic and Prognostic Biomarker of Early-Stage Lung Adenocarcinoma. J Extracell Vesicles Choi BH, An H, Cho S, Lee S, Kim HR, Cho JH, Lee JH, Kim GY, Jeon OH, Shin H, Choi Y, Kim HK. PMID: 42087680 [PubMed - indexed for MEDLINE]
	Radiation-triggered acute exacerbation of progressive fibrotic interstitial lung diseases: 'Are we advancing the frontier or crossing a dangerous line?'. Ther Adv Respir Dis Dimeas IE, Miziou A, Mitchell PD, Daniil Z, McCarthy C. PMID: 42087338 [PubMed - indexed for MEDLINE]
	Clinical validation of a high-definition mid-position magnetic resonance imaging approach for lung radiotherapy planning. Med Phys Keijnemans K, van Lier ALHMW, Borman PTS, Tekatli H, Pomp J, van Weelderen RE, Raaymakers BW, Fast MF. PMID: 42086464 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159359

Page 1 of 7968



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy